Human adrenal cells express tumor necrosis factor-α messenger ribonucleic acid: Evidence for paracrine control of adrenal function

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 807-813

  González Hernández, José A ^a,c   Ehrhart Bornstein, Monika ^a   Späth Schwalbe, Ernst ^b   Scherbaum, Werner A ^a   Bornstein, Stefan R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF HAVANA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL FUNCTION; ARTICLE; ELECTRON MICROSCOPY; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS REGULATION;

ADRENAL CORTEX; ADRENAL GLANDS; ADRENAL MEDULLA; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHROMAFFIN SYSTEM; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROSCOPY, ELECTRON; MIDDLE AGED; OLIGONUCLEOTIDE PROBES; RNA, MESSENGER; STEROID 17-ALPHA-HYDROXYLASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030064978     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.807     Document Type: Article

References (45)

1. Martin JB, Tracey KJ. 1992 Tumor necrosis factor in neuroimmunology. Adv Neuroimmunol. 2:125-138.
2. Abrahan E, Coulson WF, Schwartz MD, Allbee J. 1994 Effects of therapy with soluble tumor necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation. Clin Exp Immunol. 98:29-34.
3. Retsas S, Leslie M, Bottomley D. 1989 Intralesional tumor necrosis factor combined with interferon gamma in metastatic melanoma. Br Med J. 298: 1290-1291.
4. Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. 1992 High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalanin isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol. 10:52-60.
5. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. 1994 Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor alpha. J Clin Invest. 94:1543-1549.
6. Rusten LS, Smeland EB, Jacobsen FW, Lien E, Lesslauer W, Loetsher H. 1994 Tumor necrosis factor alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cell in vitro. Role of p55 and p75 tumor necrosis factor receptor. J Clin Invest. 94:165-172.
7. Sugarman BJ, Aggarwal BB, Hass PE, Figari FS, Palladino MA, Shepard HM. 1985 Recombinant human tumor necrosis factor alpha effects on proliferation of normal and transformed cells in vitro. Science. 234:470-474.
8. Imura H, Fukata J, Mori T. 1991 Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin Endocrinol (Oxf). 35:107-115.
9. Wick G, Hu Y, Shwarz S, Kroemer G. 1993 Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr Rev. 14:539-563.
10. Chrousos GP. 1995 The hypothalamic-pituitary-adrenal axis and immunomediated inflammation. N Engl J Med. 332:1351-1362.
11. Blalock JE. 1994 The syntax of immune-neuroendocrine communication. Immunol Today. 15:504-511.
12. Reichlin S. 1993 Neuroendocrine-immune interactions. N Engl J Med. 329: 1246-1253.
13. Milenkovic L, Rettori V, Snyder GD, Beutter B, McCann SM. 1989 Cachectin alters anterior pituitary hormone release by direct action in vitro. Proc Natl Acad Sci USA. 86:2418-2422.
14. Sharp BM, Malta SG, Peterson PK, Newton R, Chao C, McAllen K. 1989 Tumor necrosis factor alpha is a potent ACTH secretagogue: comparison to interleukin-1β. Endocrinology. 124:3131-3133.
15. Darling G, Goldstein DS, Stull R, Gorschboth CM, Norton JA. 1989 Tumor necrosis factor; immune endocrine interaction. Surgery. 106:1155-1160.
16. Jaattela M, Ilvesmaski V, Voutilainen R, Stenman UH, Saksela E. 1991 Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology. 128:623-629.
17. Jaattela M, Carpen O, Stenman UH, Saksela E. 1990 Regulation of ACTH induced steroidogenesis in human fetal adrenals by rTNF- alpha. Mol Cell Endocrinol. 68:R31-R36.
18. Natarajan R, Ploszaj S, Horton R, Nadler J. 1989 Tumor necrosis factor and interleukin 1 are potent inhibitor of angiotensin-II-induced aldosterone synthesis. Endocrinology. 125:3084-3089.
19. Khoury EL, Greenspan JS, Greenspan FS. 1987 Cells of the zona reticularis normally express HLA-DR antigenic determinants. Am J Pathol. 127:580-591.
20. Hutchinson I. 1993 Transplantation and rejection. In: Roitt I, Brostoff J, Male D, eds. Immunology. London: Mosby; 23.3-23.12.
21. 2α, oxytocin, and cytokines on steroidogenesis of porcine luteal cells. Endocrinology. 132:751-756.
22. Judd AM, McLeod RM. 1992 Adrenocorticotropin increases interleukin-6 release from rat adrenal zona glomerulosa cells. Endocrinology. 130:1245-1254.
23. González-Hernández JA, Bornstein SR, Ehrhart-Bornstein M, Späth-Schwalbe E, Jirikowski G, Scherbaum WA. 1994 Interleukin 6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function. J Clin Endocrinol Metab. 79:1492-1497.
24. González-Hernández JA, Bornstein SR, Ehrhart-Bornstein M, et al. 1995 Interleukin 1 is expressed in human adrenal gland in vivo. Possible role in a local immune-adrenal axis. Clin Exp Immunol. 99:137.
25. Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA, Pfeiffer EF, Holst JJ. 1990 Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinology. 127:900-906.
26. Bornstein SR, Ehrhart-Bornstein M. 1992 Ultrastructural evidence for a paracrine regulation of the rat adrenal cortex mediated by the local release of catecholamines from chromaffin cells. Endocrinology. 131:3126-3128.
27. Bornstein SR, González-Hernández JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA. 1994 Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab. 78:225-231.
28. González-Hernández JA, Bornstein SR, Ehrhart-Bornstein M, Gschwend JE, Adler G, Scherbaum WA. 1994 Macrophages within the human adrenal gland. Cell Tissue Res. 278:201-205.
29. Sternberger LA. 1986 Immunohistochemistry, 3rd ed. New York: Wiley and Sons.
30. Ziegler-Heitbrock HWL, Ströbel M, Kieper D, et al. 1992 Differential expression of cytokines in human blood monocytes subpopulations. Blood. 79: 503-511.
31. Judd AM. Tumor necrosis factor increases interleukin 6 release from rat adrenal zona glomerulosa cells [Abstract 399]. Proc of the 75th Annual Meeting of The Endocrine Society. 1993; 1394B.
32. Judd AM, MacLeod RM. 1995 Differential release of tumor necrosis factor and IL6 from adrenal zona glomerulosa cells in vitro. Am J Physiol. 268:E114-E120.
33. Wuttke W, Jarry H, Pitzel L, Knoke I, Spiess S. 1993 Luteotrophic and luteolytic actions of ovarian peptides. Hum Reprod. 8:141-146.
34. Tracey KJ. 1992 The acute and chronic pathophysiologic effects of TNF-mediation of septic shock and wasting (cachexia). In: Beutler B, ed. Tumor necrosis factor. New York: Plenum Press; 255-273.
35. Derijk R, van Rooijen N, Tilders FJH, Besedovky HO, del Rey A, Berkenbosh F. 1991 Selective depletion of macrophages prevent pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats. Endocrinology. 129:330-338.
36. Nakano K, Suzuki S, Oh C. 1987 Significance of increased secretion of glucocorticoids in mice and rats injected with bacterial endotoxin. Brain Behav Immunol. 1:159-172.
37. Bertini R, Bianchi M, Ghezzi P. 1988 Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med. 167:1702-1712.
38. Soni A, Wyrwinsky P, Guzman R, et al. Evidence of adrenal insufficiency in septic shock and its possible relationship to the immune response [Abstract 468]. Proc of the 75th Annual Meeting of The Endocrine Society. 1993; 167OC.
39. Hughes TK, Smith EM. 1989 Corticotropin (ACTH) induction of rumor necrosis factor alpha by monocytes. J Biol Regul Homeost Agents. 3:163-166.
40. Fraker DL, Stovroff MC, Merino MJ, Norton JA. 1988 Tolerance to tumor necrosis factor in rats and relationship to endotoxin tolerance and toxicity. J Exp Med. 168:95-105.
41. Eskay RL, Eiden LE. 1992 Interleukin 1β and tumor necrosis factor alpha differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells. Endocrinology. 130: 2252-2258.
42. Ehrhart-Bornstein M, Bornstein SR, Scherbaum WA, Pfeiffer EF, Holst JJ. 1991 Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex. Neuroendocrinology. 54:623-628.
43. Caspi RR, Roberge FG, Nussenblatt RB. 1987 Organ resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Nature. 237:1029-1032.
44. Paschke R, Kist A, Jänicke R, Eck T, Velu T, Usadel KH. 1993 Lack of intrathyroidal tumor necrosis factor alpha in Graves' disease. J Clin Endocrinol Metab. 76:97-102.
45. Jacob CO, McDevitt HO. 1988 Tumor necrosis factor in murine autoimmune "lupus" nephritis. Nature. 331:356-358.